Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| AMAROQ | - | 5 | -2,63 % | ||
 | FESTI | - | 4 | - | |
| HEIMAR | - | 3 | - | |
| JBT MAREL | - | 2 | +0,82 % | ||
| ARION BANK | - | 1 | 0,00 % | ||
| EIMSKIP | - | 1 | - | |
| ICELANDAIR GROUP HF | - | - | - | |
| HAGAR | - | - | - | |
| SKAGI | - | - | - | |
| SJOVA | - | - | - |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Amaroq Ltd.: Holding(s) in Company | 3 | GlobeNewswire (USA) | ||
| Mo | Festi hf.: Publication of Supplement to Base Prospectus | 3 | GlobeNewswire (USA) | ||
| Mo | Alvotech's AVT03 approved by European Commission as biosimilar to Prolia and Xgeva | 6 | Seeking Alpha | ||
| Mo | European Commission approves Alvotech's biosimilar denosumab | 4 | Investing.com | ||
| Mo | Europäische Kommission erteilt Alvotech Zulassung für Denosumab-Biosimilar | 5 | Investing.com Deutsch | ||
| Mo | Alvotech Announces Approval of AVT03, a Biosimilar to Prolia and Xgeva (denosumab) in the European Economic Area | 177 | GlobeNewswire (Europe) | REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen | |
| Mo | Eimskipafelag Islands hf.: Transaction in relation to a share buy-back program | 3 | GlobeNewswire (USA) | ||
| 21.11. | Nasdaq announces semi-annual changes to the OMX Iceland 15 Index: Síldarvinnslan hf. will be added and Skagi hf. will be removed from the Index | 231 | GlobeNewswire | Reykjavik, November 21, 2025 - Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the OMX Iceland 15 Index, (Nasdaq Iceland: OMXI15), which will become effective at market... ► Artikel lesen | |
| 21.11. | Alvotech and Advanz announce EC approval for Gobivaz biosimilar | 5 | Pharmaceutical Business Review | ||
| 21.11. | Alvotech and Advanz announce EC approval for Gobivaz biosimilar | 4 | Pharmaceutical Technology |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .